Hemophilia is a rare disorder in which blood doesn’t clot properly due to a lack of sufficient blood-clotting proteins. Although hemophilia doesn’t have a cure, there are treatments available to help manage it. What treatment patients receive will depend on the type of hemophilia they have. Adynovate is one of the treatments used to help patients who have hemophilia A, the most common form.
Those with hemophilia A either don’t have enough factor VIII or the clotting factor VIII isn’t working properly in them. Adynovate may be able to replace the missing clotting factor VIII temporarily.
Adynovate is an injectable medicine used to replace the antihemophilic factor missing in people with . The medication is injected directly into the patient’s bloodstream to help treat and control bleeding. It can be given to both children and adults with hemophilia A.
With regular use, Adynovate has been found to reduce the number of bleeding episodes. Adynovate is usually given to patients twice a week.
Patients who are allergic to mice or hamster protein should not use Adynovate.
There is the potential for Adynovate to stop working if the patient’s body forms inhibitors to factor VIII. Doctors can administer blood tests to check and see if inhibitors to factor VIII are developing. It is the body’s normal defense system to form inhibitors, but this may cause problems if the inhibitors begin to reduce the effectiveness of Adynovate.
Patients should not administer Adynovate to themselves unless they have been properly instructed by a doctor or healthcare professional to do so. If patients are administering the medication themselves, they need to ensure that they follow their healthcare professional’s instructions on dosage and schedule. For best results, dosage and schedule of Adynovate must be followed strictly.
Patients should talk to their doctors or to a healthcare professional to find out whether Adynovate is right for them.
Featured Image: Depositphotos © ibreakstock